383 results on '"Corvol H"'
Search Results
52. Erratum à l’article « Nouvelles thérapeutiques de la mucoviscidose ciblant le gène ou la protéine CFTR » [Rev. Mal. Respir. (2016). doi: 10.1016/j.rmr.2015.11.010]
53. Exposome inorganique et sarcoïdose pulmonaire pédiatrique : l’étude PEDIASARC
54. WS10.4 Transcriptomic analysis of normal and cystic fibrosis human bronchial epithelial cells infected with Pseudomonas aeruginosa reveals distinct gene activation
55. WS06.4 miR-9 and ANO1: Therapeutic targets in cystic fibrosis?
56. CO-25 – Couverture vaccinale et mucoviscidose pédiatrique: étude multicentrique française
57. Étude comparative du transcriptome de cellules épithéliales bronchiques, issues de sujets sains ou mucoviscidosiques, infectées par Pseudomonas aeruginosa
58. Régulation du canal chlorure ANO1 par miR-9 dans le contexte de la mucoviscidose
59. Impact de la grippe pandémique H1N1 chez les patients atteints de mucoviscidose
60. Étude de la régulation du canal chlorure ANO1 par les microARNs chez les patients atteints de mucoviscidose
61. 142 Immunisation coverage in children with cystic fibrosis: a French multicenter survey
62. SFIPP CO-01 - Imagerie de la sarcoïdose abdominale chez l’enfant
63. An idiopathic congenital chylothorax: surgery or conservative management?
64. Consensus national sur les modalités de prescription des corticoïdes inhalés dans la mucoviscidose
65. Endobronchial avium mycobacteria infection in an immunocompetent child
66. Pulmonary sarcoid-like granulomatous disease in an 11-month-old girl
67. A rare CFTR intronic mutation related to a mild CF disease in a 12-year-old girl
68. Pneumonie à Pneumocystis jiroveci au cours d’une corticothérapie prolongée chez un nourrisson immunocompétent
69. 153 Regulation of corticosteroid binding globulin (CBG) in the inflammatory context of cystic fibrosis
70. WS15.4 Study of the chloride channel ANO1 in cystic fibrosis context
71. 149* 2009 H1N1 influenza A in cystic fibrosis patients. A French collaborative study
72. Azithromycin long term effects in children with cystic fibrosis
73. Dramatic Improvement by Macrolides in Surfactant Deficiency with ABCA3 Mutation.
74. High Resolution Computed Tomography in Children with SFTPC Gene Mutation and Its Relationship to Histological Findings from the Open Lung Biopsies.
75. A new candidate biomarker of inflammation in CF airway: Amphiregulin
76. Cytokine polymorphisms influence lung disease progression in cystic fibrosis
77. 3 SPLF Printemps 2006 (bourse de voyage)
78. La prise en charge aux urgences de la crise d'asthme aiguë de l'enfant.
79. 122 Differences and similarities between circulating and airway neutrophils in cystic fibrosis
80. Neutrophil-epithelial cell crosstalk causes an amplified inflammatory response in airways of patients with cystic fibrosis
81. Influence des polymorphismes du gène TGF-béta 1 sur la fonction pulmonaire des patients atteints de mucoviscidose
82. 19 Influence of tumor necrosis factor gene polymorphisms on lung disease progression in children with Cystic Fibrosis
83. Chylothorax idiopathique chez l’enfant : prise en charge et évolution
84. Influence des polymorphismes du gène TGF- ɛ1 sur la fonction pulmonaire des patients atteints de mucoviscidose
85. Ventilation by HFO or CMV in premature neonates of less than 30 weeks' gestational age with hyaline membrane disease: functional outcome at one year
86. Ventilation Par Ohf Ou Vmc Des Nouveau-Nes Prematures De Moins De 30 Sa Atteints De Maladie Des Membranes Hyalines. évolution Fonctionnelle A 1 An
87. Nirsevimab and Hospitalization for RSV Bronchiolitis.
88. Mise à jour des recommandations (2021) pour la prise en charge et le suivi des patients asthmatiques adolescents (de 12ans et plus) sous l’égide de la société de pneumologie de langue française (SPLF) et de la société pédiatrique de pneumologie et allergologie (SP2A). Version longue partie 2
89. MIR-9 AND ANO1: THERAPEUTICS TARGETS IN CYSTIC FIBROSIS?
90. ROLE OF MIR-199A IN THE REGULATION OF INFLAMMATION IN CF BRONCHIAL EPITHELIAL CELLS
91. DETERMINATION OF ANO1 EXPRESSION, LOCALIZATION AND ACTIVITY IN CYSTIC FIBROSIS AIRWAYS
92. Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis
93. A national internet-linked based database for pediatric interstitial lung diseases: the French network
94. Influence des polymorphismes du gène TGF- ɛ 1 sur la fonction pulmonaire des patients atteints de mucoviscidose
95. Interstitial lung diseases in children
96. Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method
97. 689 Triple CFTR modulator combination improves glucose tolerance in adolescents with cystic fibrosis: data from the French observational pediatric study MODUL-CF.
98. 227 Distinct molecular responses of bronchial epithelium to SARS-CoV-2 infection: insight into preexisting respiratory conditions.
99. Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis
100. 860 Impact of seasonality and climate on acquisition of Pseudomonas aeruginosa and Staphylococcus aureus in young people with cystic fibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.